LEIK FNP Exam Prep Document | 2026/2027 Edition | 250
Verified Questions
LEIK FNP Exam QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest NGN & HESI Guidelines | Graded A+
This comprehensive exam preparation guide features 250 meticulously verified questions and answers
designed for the LEIK Family Nurse Practitioner (FNP) exam. Aligned with the latest NGN and HESI
guidelines for the 2026-2027 academic year, each question includes detailed rationales and distractor
explanations to reinforce clinical reasoning. Ideal for students seeking a graded A+ performance, this
resource covers core FNP competencies with evidence-based content.
Key Features:
250 verified multiple-choice questions with correct answers
Detailed rationales for correct and incorrect options
Updated per latest NGN and HESI exam guidelines
Covers health assessment, pharmacology, and disease management
Organized by content area for targeted study
Graded A+ solutions with step-by-step explanations
Updates for 2026:
- Integrated 2026-2027 NGN clinical judgment models
- Revised pharmacology content per latest FDA approvals
- Added new questions on telehealth and chronic disease management
- Updated rationales with evidence-based practice references
- Enhanced distractor explanations to clarify common misconceptions
Abstract:
The LEIK FNP Exam Prep Document is a rigorous study tool containing 250 verified questions and answers
tailored to the Family Nurse Practitioner certification exam. Each question is aligned with the National Council
Licensure Examination (NCLEX) Next Generation (NGN) and Health Education Systems, Inc. (HESI) guidelines
for the 2026-2027 academic year. The content spans essential FNP domains including advanced health assessment,
pharmacotherapeutics, and primary care management across the lifespan. Rationales are provided for both
correct and incorrect answers, emphasizing clinical judgment and evidence-based decision-making. This resource
is designed to facilitate mastery of core competencies, with a focus on high-yield topics and frequently tested
concepts. The document's structured format allows for systematic review, while the graded A+ solutions ensure
learners understand the reasoning behind each answer. Updated to reflect current practice standards, this guide is
an indispensable asset for FNP candidates aiming to excel on their certification exam.
Keywords:
LEIK FNP exam, Family Nurse Practitioner, NGN guidelines, HESI guidelines, 250 questions, graded A+, clinical
judgment, exam prep
Answer Format:
Each question is followed by the correct answer and a detailed rationale explaining why it is correct, along with
explanations for each distractor to clarify common errors. Answers are formatted in bold for quick identification,
with rationales in plain text beneath.
Compliance Checklist:
Aligned with 2026-2027 NGN and HESI guidelines
All questions verified for accuracy by subject matter experts
Page 1
, Rationales cite current evidence-based practice references
Content covers all major FNP exam domains
Distractor explanations address typical student misconceptions
Format optimized for both digital and print study
Content Area Overview:
Content Area Questions Key Topics Weight
Advanced Health Assessment 1-50 History taking, physical exam techniques, 20%
diagnostic reasoning, documentation
Pharmacotherapeutics 51-100 Drug classifications, pharmacokinetics, 20%
prescribing guidelines, adverse effects
Primary Care Management: 101-150 Infections, injuries, minor procedures, 20%
Acute Conditions urgent care
Primary Care Management: 151-200 Hypertension, diabetes, asthma, heart 20%
Chronic Conditions failure, COPD
Health Promotion & Disease 201-250 Screening guidelines, immunizations, 20%
Prevention lifestyle counseling, preventive care
Page 2
,Q1. A patient with a history of recurrent urinary tract infections presents with dysuria, frequency, and
suprapubic pain. Urinalysis shows pyuria and bacteriuria, but urine culture is negative. Which of the
following best explains this discordance?
A. Recent antibiotic use within the past 48 hours
B. Infection with a fastidious organism such as Ureaplasma urealyticum
C. Contamination of the specimen with vaginal flora
D. Renal calculi causing sterile pyuria
Correct Answer: B. Infection with a fastidious organism such as Ureaplasma urealyticum
Rationale: Fastidious organisms like Ureaplasma urealyticum require special culture media and may not grow on
standard urine culture, leading to negative culture despite significant pyuria and symptoms. Recent antibiotic use
(A) could suppress growth but would typically show fewer bacteria, not pyuria. Contamination (C) would show
mixed flora, not pure pyuria. Sterile pyuria from calculi (D) usually lacks bacteriuria and is less likely with dysuria
and frequency.
Why Wrong:
A - Recent antibiotics would suppress bacterial growth, but pyuria and bacteriuria on urinalysis suggest active
infection, making this less likely.
C - Contamination typically yields mixed flora and epithelial cells, not pure pyuria with bacteriuria.
D - Renal calculi cause sterile pyuria without bacteriuria; presence of bacteriuria on urinalysis points to
infection.
Reference: Graves, N. (2023). Urinary tract infections in adults. In: Current Diagnosis & Treatment in Family
Medicine, 5th Ed., Ch. 22.
Q2. A patient with type 2 diabetes and stage 3 chronic kidney disease (eGFR 35 mL/min) is being started on a
GLP-1 receptor agonist for glycemic control. Which of the following agents is most appropriate given the
renal function?
A. Liraglutide
B. Semaglutide (oral)
C. Dulaglutide
D. Exenatide
Correct Answer: C. Dulaglutide
Rationale: Dulaglutide is not significantly renally excreted and can be used without dose adjustment in CKD stage
3. Liraglutide (A) is also safe but requires dose adjustment at lower eGFR; semaglutide oral (B) is contraindicated
with eGFR <30; exenatide (D) is contraindicated with eGFR <30 due to increased risk of acute kidney injury.
Dulaglutide has the best safety profile in this setting.
Why Wrong:
A - Liraglutide can be used but requires monitoring; it is not the most appropriate due to less evidence in
CKD stage 3 compared to dulaglutide.
B - Oral semaglutide is contraindicated with eGFR <30, and its use in stage 3 is not recommended due to
limited data.
D - Exenatide is contraindicated with eGFR <30, and its use in stage 3 is associated with renal adverse events.
Reference: American Diabetes Association. (2024). Pharmacologic approaches to glycemic treatment. Diabetes
Care, 47(Suppl 1), S158-S178.
Q3. A patient presents with acute-onset vertigo, nausea, and nystagmus that is horizontal and unidirectional,
with a normal neurological exam. The Dix-Hallpike maneuver is negative. Which of the following is the most
likely diagnosis?
A. Vestibular neuritis
B. Benign paroxysmal positional vertigo (BPPV)
C. Ménière's disease
Page 3
, D. Central vertigo due to brainstem stroke
Correct Answer: A. Vestibular neuritis
Rationale: Vestibular neuritis typically presents with acute severe vertigo, nausea, and horizontal unidirectional nystagmus
that is suppressed by visual fixation; the Dix-Hallpike is negative. BPPV (B) is triggered by positional changes and has a
positive Dix-Hallpike. Ménière's (C) includes fluctuating hearing loss and tinnitus, not acute onset alone. Central vertigo (D)
would show direction-changing nystagmus or other neurological signs.
Why Wrong:
B - BPPV is triggered by head position changes and would have a positive Dix-Hallpike maneuver.
C - Ménière's disease presents with episodic vertigo, hearing loss, tinnitus, and aural fullness, not acute isolated vertigo.
D - Central vertigo typically produces nystagmus that is vertical or direction-changing, and often includes other
brainstem signs.
Reference: Furman, J.M., & Whitney, S.L. (2023). Vestibular disorders. In: Current Diagnosis & Treatment in Neurology, 4th
Ed., Ch. 15.
Q4. A patient with a history of hypertension is found to have a serum potassium of 3.2 mEq/L while taking
hydrochlorothiazide 25 mg daily. The patient denies muscle cramps or palpitations. Which of the following is
the most appropriate next step in management?
A. Discontinue hydrochlorothiazide and start amlodipine
B. Add a potassium-sparing diuretic such as spironolactone
C. Start oral potassium chloride 20 mEq daily and recheck in one week
D. No action needed; this is an expected effect
Correct Answer: C. Start oral potassium chloride 20 mEq daily and recheck in one week
Rationale: Thiazide diuretics commonly cause hypokalemia. With a potassium of 3.2 mEq/L (moderate
hypokalemia), replacement is indicated even if asymptomatic, as it increases risk of arrhythmias. Oral potassium
chloride is first-line. Adding a potassium-sparing diuretic (B) is an option but not first-step; it may be considered if
hypokalemia persists despite replacement. Discontinuing the thiazide (A) is not necessary if hypokalemia can be
corrected. No action (D) is incorrect because hypokalemia requires intervention.
Why Wrong:
A - Discontinuation is not necessary; thiazides are effective antihypertensives and hypokalemia is
manageable.
B - Adding a potassium-sparing diuretic is a reasonable second-line option but not the first step; replacement
is simpler.
D - Hypokalemia of this degree is not benign and requires correction to prevent cardiac complications.
Reference: Whelton, P.K., et al. (2022). 2022 ACC/AHA guideline for the prevention, detection, evaluation, and
management of high blood pressure in adults. Hypertension, 79(1), e1-e52.
Q5. A patient with a history of opioid use disorder (OUD) on buprenorphine/naloxone maintenance presents
with acute pain from a fractured femur. Which of the following is the most appropriate pain management
strategy?
A. Discontinue buprenorphine and use full mu-opioid agonists as needed
B. Continue buprenorphine and add a nonsteroidal anti-inflammatory drug (NSAID)
C. Continue buprenorphine and add a short-acting full mu-opioid agonist with higher doses due to tolerance
D. Discontinue buprenorphine and initiate methadone for both OUD and pain
Correct Answer: C. Continue buprenorphine and add a short-acting full mu-opioid agonist with higher doses
due to tolerance
Rationale: In acute severe pain, buprenorphine should be continued to maintain OUD treatment, and a full
mu-opioid agonist (e.g., fentanyl, morphine) can be added at higher doses because buprenorphine's high receptor
affinity may require increased doses of the agonist to achieve analgesia. Discontinuing buprenorphine (A, D) risks
relapse and withdrawal. NSAIDs alone (B) are insufficient for severe fracture pain.
Page 4
Verified Questions
LEIK FNP Exam QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest NGN & HESI Guidelines | Graded A+
This comprehensive exam preparation guide features 250 meticulously verified questions and answers
designed for the LEIK Family Nurse Practitioner (FNP) exam. Aligned with the latest NGN and HESI
guidelines for the 2026-2027 academic year, each question includes detailed rationales and distractor
explanations to reinforce clinical reasoning. Ideal for students seeking a graded A+ performance, this
resource covers core FNP competencies with evidence-based content.
Key Features:
250 verified multiple-choice questions with correct answers
Detailed rationales for correct and incorrect options
Updated per latest NGN and HESI exam guidelines
Covers health assessment, pharmacology, and disease management
Organized by content area for targeted study
Graded A+ solutions with step-by-step explanations
Updates for 2026:
- Integrated 2026-2027 NGN clinical judgment models
- Revised pharmacology content per latest FDA approvals
- Added new questions on telehealth and chronic disease management
- Updated rationales with evidence-based practice references
- Enhanced distractor explanations to clarify common misconceptions
Abstract:
The LEIK FNP Exam Prep Document is a rigorous study tool containing 250 verified questions and answers
tailored to the Family Nurse Practitioner certification exam. Each question is aligned with the National Council
Licensure Examination (NCLEX) Next Generation (NGN) and Health Education Systems, Inc. (HESI) guidelines
for the 2026-2027 academic year. The content spans essential FNP domains including advanced health assessment,
pharmacotherapeutics, and primary care management across the lifespan. Rationales are provided for both
correct and incorrect answers, emphasizing clinical judgment and evidence-based decision-making. This resource
is designed to facilitate mastery of core competencies, with a focus on high-yield topics and frequently tested
concepts. The document's structured format allows for systematic review, while the graded A+ solutions ensure
learners understand the reasoning behind each answer. Updated to reflect current practice standards, this guide is
an indispensable asset for FNP candidates aiming to excel on their certification exam.
Keywords:
LEIK FNP exam, Family Nurse Practitioner, NGN guidelines, HESI guidelines, 250 questions, graded A+, clinical
judgment, exam prep
Answer Format:
Each question is followed by the correct answer and a detailed rationale explaining why it is correct, along with
explanations for each distractor to clarify common errors. Answers are formatted in bold for quick identification,
with rationales in plain text beneath.
Compliance Checklist:
Aligned with 2026-2027 NGN and HESI guidelines
All questions verified for accuracy by subject matter experts
Page 1
, Rationales cite current evidence-based practice references
Content covers all major FNP exam domains
Distractor explanations address typical student misconceptions
Format optimized for both digital and print study
Content Area Overview:
Content Area Questions Key Topics Weight
Advanced Health Assessment 1-50 History taking, physical exam techniques, 20%
diagnostic reasoning, documentation
Pharmacotherapeutics 51-100 Drug classifications, pharmacokinetics, 20%
prescribing guidelines, adverse effects
Primary Care Management: 101-150 Infections, injuries, minor procedures, 20%
Acute Conditions urgent care
Primary Care Management: 151-200 Hypertension, diabetes, asthma, heart 20%
Chronic Conditions failure, COPD
Health Promotion & Disease 201-250 Screening guidelines, immunizations, 20%
Prevention lifestyle counseling, preventive care
Page 2
,Q1. A patient with a history of recurrent urinary tract infections presents with dysuria, frequency, and
suprapubic pain. Urinalysis shows pyuria and bacteriuria, but urine culture is negative. Which of the
following best explains this discordance?
A. Recent antibiotic use within the past 48 hours
B. Infection with a fastidious organism such as Ureaplasma urealyticum
C. Contamination of the specimen with vaginal flora
D. Renal calculi causing sterile pyuria
Correct Answer: B. Infection with a fastidious organism such as Ureaplasma urealyticum
Rationale: Fastidious organisms like Ureaplasma urealyticum require special culture media and may not grow on
standard urine culture, leading to negative culture despite significant pyuria and symptoms. Recent antibiotic use
(A) could suppress growth but would typically show fewer bacteria, not pyuria. Contamination (C) would show
mixed flora, not pure pyuria. Sterile pyuria from calculi (D) usually lacks bacteriuria and is less likely with dysuria
and frequency.
Why Wrong:
A - Recent antibiotics would suppress bacterial growth, but pyuria and bacteriuria on urinalysis suggest active
infection, making this less likely.
C - Contamination typically yields mixed flora and epithelial cells, not pure pyuria with bacteriuria.
D - Renal calculi cause sterile pyuria without bacteriuria; presence of bacteriuria on urinalysis points to
infection.
Reference: Graves, N. (2023). Urinary tract infections in adults. In: Current Diagnosis & Treatment in Family
Medicine, 5th Ed., Ch. 22.
Q2. A patient with type 2 diabetes and stage 3 chronic kidney disease (eGFR 35 mL/min) is being started on a
GLP-1 receptor agonist for glycemic control. Which of the following agents is most appropriate given the
renal function?
A. Liraglutide
B. Semaglutide (oral)
C. Dulaglutide
D. Exenatide
Correct Answer: C. Dulaglutide
Rationale: Dulaglutide is not significantly renally excreted and can be used without dose adjustment in CKD stage
3. Liraglutide (A) is also safe but requires dose adjustment at lower eGFR; semaglutide oral (B) is contraindicated
with eGFR <30; exenatide (D) is contraindicated with eGFR <30 due to increased risk of acute kidney injury.
Dulaglutide has the best safety profile in this setting.
Why Wrong:
A - Liraglutide can be used but requires monitoring; it is not the most appropriate due to less evidence in
CKD stage 3 compared to dulaglutide.
B - Oral semaglutide is contraindicated with eGFR <30, and its use in stage 3 is not recommended due to
limited data.
D - Exenatide is contraindicated with eGFR <30, and its use in stage 3 is associated with renal adverse events.
Reference: American Diabetes Association. (2024). Pharmacologic approaches to glycemic treatment. Diabetes
Care, 47(Suppl 1), S158-S178.
Q3. A patient presents with acute-onset vertigo, nausea, and nystagmus that is horizontal and unidirectional,
with a normal neurological exam. The Dix-Hallpike maneuver is negative. Which of the following is the most
likely diagnosis?
A. Vestibular neuritis
B. Benign paroxysmal positional vertigo (BPPV)
C. Ménière's disease
Page 3
, D. Central vertigo due to brainstem stroke
Correct Answer: A. Vestibular neuritis
Rationale: Vestibular neuritis typically presents with acute severe vertigo, nausea, and horizontal unidirectional nystagmus
that is suppressed by visual fixation; the Dix-Hallpike is negative. BPPV (B) is triggered by positional changes and has a
positive Dix-Hallpike. Ménière's (C) includes fluctuating hearing loss and tinnitus, not acute onset alone. Central vertigo (D)
would show direction-changing nystagmus or other neurological signs.
Why Wrong:
B - BPPV is triggered by head position changes and would have a positive Dix-Hallpike maneuver.
C - Ménière's disease presents with episodic vertigo, hearing loss, tinnitus, and aural fullness, not acute isolated vertigo.
D - Central vertigo typically produces nystagmus that is vertical or direction-changing, and often includes other
brainstem signs.
Reference: Furman, J.M., & Whitney, S.L. (2023). Vestibular disorders. In: Current Diagnosis & Treatment in Neurology, 4th
Ed., Ch. 15.
Q4. A patient with a history of hypertension is found to have a serum potassium of 3.2 mEq/L while taking
hydrochlorothiazide 25 mg daily. The patient denies muscle cramps or palpitations. Which of the following is
the most appropriate next step in management?
A. Discontinue hydrochlorothiazide and start amlodipine
B. Add a potassium-sparing diuretic such as spironolactone
C. Start oral potassium chloride 20 mEq daily and recheck in one week
D. No action needed; this is an expected effect
Correct Answer: C. Start oral potassium chloride 20 mEq daily and recheck in one week
Rationale: Thiazide diuretics commonly cause hypokalemia. With a potassium of 3.2 mEq/L (moderate
hypokalemia), replacement is indicated even if asymptomatic, as it increases risk of arrhythmias. Oral potassium
chloride is first-line. Adding a potassium-sparing diuretic (B) is an option but not first-step; it may be considered if
hypokalemia persists despite replacement. Discontinuing the thiazide (A) is not necessary if hypokalemia can be
corrected. No action (D) is incorrect because hypokalemia requires intervention.
Why Wrong:
A - Discontinuation is not necessary; thiazides are effective antihypertensives and hypokalemia is
manageable.
B - Adding a potassium-sparing diuretic is a reasonable second-line option but not the first step; replacement
is simpler.
D - Hypokalemia of this degree is not benign and requires correction to prevent cardiac complications.
Reference: Whelton, P.K., et al. (2022). 2022 ACC/AHA guideline for the prevention, detection, evaluation, and
management of high blood pressure in adults. Hypertension, 79(1), e1-e52.
Q5. A patient with a history of opioid use disorder (OUD) on buprenorphine/naloxone maintenance presents
with acute pain from a fractured femur. Which of the following is the most appropriate pain management
strategy?
A. Discontinue buprenorphine and use full mu-opioid agonists as needed
B. Continue buprenorphine and add a nonsteroidal anti-inflammatory drug (NSAID)
C. Continue buprenorphine and add a short-acting full mu-opioid agonist with higher doses due to tolerance
D. Discontinue buprenorphine and initiate methadone for both OUD and pain
Correct Answer: C. Continue buprenorphine and add a short-acting full mu-opioid agonist with higher doses
due to tolerance
Rationale: In acute severe pain, buprenorphine should be continued to maintain OUD treatment, and a full
mu-opioid agonist (e.g., fentanyl, morphine) can be added at higher doses because buprenorphine's high receptor
affinity may require increased doses of the agonist to achieve analgesia. Discontinuing buprenorphine (A, D) risks
relapse and withdrawal. NSAIDs alone (B) are insufficient for severe fracture pain.
Page 4
